ArticlePDF Available

Gastrointestinal Tract Infections With Human Cytomegalovirus And Mycobacterium Tubercolusis

Authors:
Archives of Clinical Microbiology
1989-8436
2022
1
© Under License of Creative Commons Attribution 3.0 License |
Research Article
It Medical Team
https://www.itmedicalteam.pl/
Gasterointesnal Tract Infecons
With Human Cytomegalovirus And
Mycobacterium Tubercolusis
Alireza Mohebbi1*,
Fahimeh Azadi2, Touba
Ghorbanzadeh3, Shabnam
Naderifar4
1 Laboratory Sciences Research Center,
Golestan University of Medical Sciences,
Gorgan, Iran
2 Department of Microbiology, School of
Medicine, Golestan University of Medical
Sciences, 4934174515, Gorgan, Iran
3 Department of Microbiology, Tehran
North Branch, Islamic Azad University of
Tehran, 1111743765, Tehran, Iran
4 Department of Microbiology, Karaj
Branch, Islamic Azad University,
1451685645, Karaj, Iran
Corresponding author:
Alireza Mohebbi
Mohebbi-a@goums.ac.ir
Tel: +98 935 467 4593
Department of Microbiology, School of
Medicine, Golestan University of Medical
Sciences, 4934174515, Gorgan, Iran
Citaon: Mohebbi A, Azadi F, Ghorbanzadeh
T, et al. (2022) Gasterointesnal Tract
Infecons With Human Cytomegalovirus
And Mycobacterium Tubercolusis. Arch
Introducon
Gastrointesnal (GI) diseases encompass complicaons ranging
from the mouth to the anus. GI includes esophageal, stomach,
intesne, liver, pancreas, gallbladder, and biliary tract ailments.
Common manifestaons of GI disorders include epigastric
pains or tenderness and distenon, gastrointesnal bleeding,
intesnal obstrucon, and malabsorpon [1,2]. Infecous agents
can also aect GI tract inammaon or gastris [3]. H. pylori-
associated gastris is the most common cause of gastris in the
world. Several other H. pylori-negave gastris is autoimmune
gastris [3], gastris due to infecous agents Mycobacterium
tuberculosis (M. tuberculosis) [4], Cytomegalovirus (MCV) [3],
Herpes Simplex virus (HSV) [6], radiaon gastris, collagenous
gastris, eosinophilic gastris, Sarcoidosis-associated gastris,
lymphocyc gastris, Ischemic gastris, Crohn disease-associated
gastris, vasculis-associated gastris, and Ménétrier disease [7].
In parcular, CMV infecon occurs almost only in
immunocompromised paents, especially in transplant
recipients. CMV infecon in immunocompetent paents is
usually asymptomac or, if symptomac, most commonly causes
a mononucleosis-like syndrome [8]. CMV can aect any organ in
these paents, with the most common site of infecon being the
Abstract
Gastrointesnal (GI) diseases due to infecous agents Mycobacterium tuberculosis
and Human Cytomegalovirus (HMCV) in immunocompetent paents are usually
asymptomac and are related to rare cases of GI complicaons. The present study
reviews the most prevalent clinical ndings and GI tract symptoms of CMV and
TB cases for a beer prognosis and therapeuc approaches. Epigastric pain or
tenderness is the most reported symptom in paents with HCMV infecon of the
GI tract. Paents may develop a fever in some cases with antrum ulcers (~39°C).
Edema is also reported in young adults and children, mainly depicted on the
feet or face. Similarly, epigastric pain is the main symptom observed in paents
with gastric TB. Weight loss due to decreased appete, nausea, and voming
in TB paents was also reported. The diagnosis of gastric CMV and TB could be
symptomac. Clinical ndings, including posive an-CMV IgM and endoscopic
enlarged gastric folds and high liver enzymes with hypo (proteinemia) albuminemia,
can be the indicaons of gastric CMV in immunocompetent paents. Addionally,
a posive PCR of acid-fast bacilli and endoscopy of necroc epithelial cells can
be the signs of gastric TB. Gastric infecon can lead to further complicaons and
gastric cancer, which increases the disease's burden and cost and lengthens the
period of treatment. The clinical ndings and symptoms of gastris caused by
CMV and TB are reported in this paper. Understanding gastris infecons might
improve the clinical outcome of the condion by allowing beer prognosis and
earlier therapeuc intervenons.
Keywords: Gastris; Gastrointesnal tract infecon; Human Cytomegalovirus;
Mycobacterium tuberculosis; Prognosis
Received: 02-July-2022, Manuscript No. ipacm-22-12662; Editor assigned: 04-July-2022, Pre-
qc No. ipacm-22-12662 (PQ); Reviewed: 19-July-2022, QC No. ipacm-22-12662 (Q) Revised: 25-
july-2022, Manuscript No. ipacm-22-12662 (R); Published: 30-July-2022, DOI: 10.36648/1989-
8436X.22.13.7.193
Vol. 13 No. 7: 193
Clinic Microbio, Vol. 13 No. 7: 193.
2022
2
Archives of Clinical Microbiology
1989-8436
gastrointesnal tract. CMV disease of the GI tract is dened by
infecon and the presence of macroscopic pathological features
or signicant GI symptoms [9]. Endoscopic features associated
with gastric CMV infecon, including ulcers and erosions, were
observed in most cases [10]. In the diagnosis of CMV-associated
GI infecon, it is crucial to detect the presence of the virus in the
mucosa of the upper GI tract. In addion, CMV serology can help
disnguish primary infecon from CMV reacvaon.
In the case of TB, the most common form of the disease is
the pulmonary form, and involvement of other organs is less
common. However, it is vital that in immunosuppressed paents,
such as those infected with human immunodeciency virus (HIV),
the risk of coinfecon CMV with TB in the gastrointesnal tract
increases due to immune system defect [11,12]. Gastrointesnal
tuberculosis can be caused by the entry of infected respiratory
tract secreons into the abdomen and cause granulomatous
inammaon. Diagnosing abdominal tuberculosis can be
challenging because it can be confused with other abdominal
diseases such as malignancy and inammatory bowel disease.
The most common symptoms include weight loss followed by
abdominal pain, sweats, and fever. The most common site of
involvement in the abdomen was the lymph nodes and then
the peritoneum. TB can be acvated in infected people under
such circumstances that the immune system is disrupted, and
coinfecon CMV with TB can also lead to serious damages in
infected people [13]. According to available data, paents with
TB are more likely to become infected with CMV. Also, CMV
can cause TB acvity in infected individuals. In addion to lung
involvement, tuberculosis can aect other body parts, especially
when co-infected with CMV [14].
Developing a new model using the clinical ndings and symptoms
could be helpful for clinicians to predict rare cases of gastric CMV
and TB infecons. Therefore, this review summarizes the previous
reports of GI infecons with CMV and TB to discriminate against
both infecons.
GI infecon of HCMV
Human Cytomegalovirus (HCMV) is a DNA virus belonging to
the Herpesviridae family. CMV has been increasingly recognized
as an important common pathogen in an immunocompromised
state [15], including individuals with AIDS and organ transplant
recipients [16,17]. An increased number of cases of gastrointesnal
diseases caused by HCMV infecon has been reported (18,19).
The colon and stomach are the most common sites of GI infecon
(20), and CMV infecon of GI is rare, especially in those with
normal immunity.
CMV might infect epithelial cells of the GI tract by infected body
uid through an unknown mechanism. Symptoms of CMV-
associated gastric disease are varied. In the immunocompetent
paents, diarrhea was reported as the most common symptom
along with other common symptoms, including weight loss, fever,
hematochezia, dysphagia, abdominal distension, and abdominal
pain (8). Several case reports were invesgated in this review to
idenfy specic CMV-associated symptoms (Table 1). The ndings
show that epigastric pain or tenderness is the most reported
symptom in paents with HCMV infecon of the GI tract. It could
also lead to weight loss and voming due to decreased appete
in paents with CMV-iduced gastric ulcers, which, if remained
untreated, might be accompanied by anorexia and nausea (Table 1).
In some cases with antrum ulcers, paents may suer from fever
(~39 °C). One of the important symptoms in paents with CMV
infecon is decreased movement acvity. Edema is also reported
in younger adults and children, mainly represented on feet or
face (Figure 1).
Clinical ndings can give a good prognosis for CMV infecon
in paents referred with GI tract complicaons. CMV in
immunocompetent paents is rare, and its dierenaon
requires a quick and comprehensive intervenon, like endoscopic,
immunohistochemical, serological, and biochemical processes.
The endoscopy address the involvement of GI tract infecon,
including enlarged gastric fold, ulcers (mainly in antrum and furus),
and surface mucosal erosions. Thickness or enlarged gastric folds
was the main endoscopic nding in CMV posive GI tract infecon
paents. Addionally, there are several ways to detect CMV
infecon based on the stage of the disease. Serological methods
are used in cases in which an increased ter of IgM anbodies
indicates acve infecon. In the case of CMV infecon, especially
in immunosuppressed paents, IgM seroconversion can indicate
CMV reacvaon that is accompanied by IgG seroposivity.
Serologically, however, an-CMV IgG or IgM or both could be
observed in immunocompetent paents.
Further methods of HCMV detecon are Cytomegalovirus
angenemia for diagnosing the infecon in its early stages and
histology and observing an intranuclear cytomegalic Owl’s eye
inclusion bodies. Further ndings of CMV infecon of the GI tract
Author Year Study Country Case Coinfecons Ref.
Kim et al. 2020 Case report South Korea A 43-year-olvd woman presented with stage iii malignant melanoma - -21
Tard et al. 2019 Case report France A 7-year-old girl & a ve-and-a-half years old girl - -22
Xiong et al. 2018 Case report China A 44-year-old man - -23
Yamamoto et al. 2018 Case report Japan A 35-year-old man EBV -24
Liu et al. 2017 Case report Taiwan A 77-year-old woman - -25
Ueno et al. 2017 Case report Japan An 80-year-old woman H. pylori -26
Wang et al. 2016 Case report China A 26-year-old man H. pylori -27
Gökçe et al. 2016 Case report Turkey An 11-year-old boy, a 3-month-old boy, & a 2-month-old boy - -28
Crespo et al. 2015 Case report Portugal A 31-year-old man - -29
Baek et al. 2015 Case report South Korea An 8-year-old girl - -30
Keskar et al. 2015 Case report India A 42-year-old woman & a 32-year-old man - -31
Peixoto et al. 2013 Case report Portugal A 71 years-old man HSV-1 and EBV -32
Table 1. Case reports of CMV gastris
Vol. 13 No. 7: 193
3
2022
© Under License of Creative Commons Attribution 3.0 License
Archives of Clinical Microbiology
1989-8436
are Hypoalbuminia and hypoproteinemia, which can be observed
in both or one of each. Furthermore, in some cases, increased
liver enzymes ALT and AST have been observed.
The majority of cases of GI tract HCMV infecon paents are
asymptomac. In those cases with the symptoms menoned
above and clinical ndings, therapeuc intervenons should
be started. Acyclovir, Gancyclovir, or Valgancyclovir have been
shown to signicantly reduce the symptoms of the disease in
two or three months, and the recurrence of the disease is not
reported.
Mycobacterium tuberculosis infecon of GI tract
Tuberculosis (TB) is one of the oldest known human diseases
caused by the Mycobacterium tuberculosis (M. tuberculosis)
complex (MTBC). Despite a long history of understanding and
treang TB, it remains the most important infecous pathogen
globally and one of the ten leading causes of death worldwide.
It is reported that M. tuberculosis is responsible for 15% of
extrapulmonary infecons, which may or may not be associated
with pulmonary symptoms. Extrapulmonary infecons are
cervical lymphadenis, pleural involvement, central nervous
system (CNS) infecon, and GI infecon. GI is the sixth most
common site of extrapulmonary TB, and it is mainly associated
with pulmonary TB or immune deciencies. Furthermore, GI
infecon with TB is also reported in rare cases without evidence
of pulmonary involvement.
Gastric TB can be caused by the entry of infected respiratory
tract secreons into the abdomen and cause granulomatous
inammaon. Diagnosing abdominal tuberculosis can be
challenging because it can be confused with other abdominal
diseases such as malignancy and inammatory bowel disease.
Symptoms of gastric TB include cough, with or without fever,
diarrhea, weight loss, voming, and hematemesis. Here, we
have classied the disease symptoms of GI tract infecon with
TB according to their prevalences in several case reports (Table
2). As shown in Figure 1, epigastric pains are the main symptoms
observed in paents with GI tract infecon of TB. It also leads
to weight loss due to decreased appete, nausea, and voming
in paents with TB-induced gastric ulcers, which, if remained
untreated, might be accompanied by anorexia and conspaon.
The inamed site of infecon may also cause fever in some cases.
The clinical ndings of TB infecon of the GI tract are also varying.
(Table 2).
Endoscopically gastric TB presents frequently as a non-healing
chronic ulcer gastric perforaon, and erosions or lesions mimicking
malignancy. In addion, Nodular hypertrophic lesions sensing
the pylorus have been reported. As shown in Figure 1, caseang
granulomatous with necrosis and gastric epithelial ulcers and
inammaon of the involved ssuse are more prevalent clinical
ndings.
The diagnosis of gastric TB can be made on histopathological
examinaon, which shows caseang epithelioid cell granulomas,
the bacteriologic study of the biopsies based on acid-fast bacilli
staining or cultures to detect M. tuberculosis, and fast and accurate
polymerase chain reacon (PCR). Almost all cases of GI tract TB
infecon reported posive PCR. This implicates a sensive PCR as a
good prognosis for TB infecon in the cases of GI tract complicaons
in immunocompetent with unknown eology and history. It can also
be suggested that acid-fast staining along with PCR can be a beer
prognosis of GI tract infecon of TB than each alone.
Treatment of abdominal tuberculosis consists of two courses
of treatment; in the rst period, the paent uses four drugs of
rifampin, isoniazid, pyrazinamide, ethambutol for two months,
Figure 1 The most prevalent clinical ndings and disease
manifestaons of gastrointesnal tract infecon with
CMV and TB.
Author Year Study Country Case Coinfecons Ref.
Ma et al. 2019 Case
report China A 26-year-
old female - -45
Espinoza-Ríos 2017 Case
report Peru A 30-year-
old female HIV -44
Nayyar et al. 2016 Case
report USA A 49-year-
old female HIV -46
Ecka et al. 2013 Case
report India A 31-year-
old male - -42
Kang et al. 2012 Case
report Korea A 54-year
old female - -47
Moghadam
et al. 2012 Case
report Iran A 43-year-
old male - -48
Khan et al. 2008 Case
report Qatar A 29-year-
old man - -43
Table 2. Case reports of TB gastris.
Vol. 13 No. 7: 193
2022
4
Archives of Clinical Microbiology
1989-8436
and in the second-period paent uses two drugs of rifampin,
isoniazid for four months.
Discussion
Health care costs and burden of GI diseases are more than other
prevalent ailments rising further. Among common causes of GI
tract diseases, some opportunisc pathogens are associated
with rare cases of GI complicaons. Accurate diagnosis and
idencaon of such pathogens help to improve disease
symptoms. HCMV and M. tuberculosis are reported in several
immunocompetent paents with GI complicaons. In the present
study, the most prevalent clinical ndings and disease symptoms
of both CMV and TB cases of GI tract infecon are reviewed for
beer diagnosis and therapeuc intervenons.
Epigastric tenderness or pain is the most common symptom in
immunocompetent paents with CMV gastris. Accordingly, the
most common sites of gastrointesnal CMV infecon are the
colon and stomach. Enlarged gastric folds and ulcers are also the
most common macroscopic manifestaons of Cytomegalovirus
infecon in antrum or furus. Gastris with CMV infecon can be
diagnosed in abdominal pains, weight loss, and voming cases.
Children may also present supercial edema on their feet or
face, which is self-liming. This might be due to congenital CMV
infecons, acquired from parents with acve CMV infecon, or
reacve infecon due to immunotherapy or some illness like
Menetrier disease. However, the laer needs to invesgate
in the future. As endoscopic ndings like gastrointesnal
ulcers are dicult to nd, dierenaon tests could benet
from a seroposive IgM with or without IgG. Furthermore,
increased levels of liver enzymes along with hypo (proteinemia)
albuminemia could be the prognosis factors of gastric CMV
infecon. Furthermore, the fecal-oral transmission of CMV in
paents with posive gastric infecon remains unidened
(Figure 2).
Gastric TB is even more uncommon due to high acidity and lack
of gastric mucosal lymphoid ssue but is usually associated with
an immunodecient state, parcularly with HIV infecon. The
most common sites of TB lesions are in the antrum and prepyloric
regions. Ileocecal and jejunal regions usually include more than
60% of gastric TB cases. The clinical manifestaons of gastric
tuberculosis are nonspecic. It can be seen as a fever of unknown
origin, and it must be dierenated from Crohn's disease,
sarcoidosis, syphilis, mycoc lesions, and exposure to beryllium,
silicates, or reserpine. A posive PCR for acid-fast bacilli can be
the diagnosc tool for paents admied with epigastric pains,
weight loss, or decreased acvity, with or without fever. Acid-fast
staining can somemes show false negaves, PCR can diagnose.
A coinfecon of TB and CMV has also been reported by Stockdale
et al.,. The results of this case-control study on persons with
undiagnosed TB showed that a posive an-CMV IgG indicates
a higher risk of TB infecon. This suggests that CMV infecon
may vulnerable paents for future infecons with opportunisc
pathogens.
Conclusion
Gastrointesnal ulcers and lesions may induce anemia or, in a
worse scenario, gastric cancer, increase the burden and cost
of the disease, and in the case of infecous agents, it may also
extend the duraon of treatment. This study summarizes the
clinical ndings and symptoms of gastris with CMV and TB.
Understanding gastris infecons would enhance the clinical
outcome of disease by faster intervenons and therapy. Further
studies can expand our knowledge on the molecular basis of GI
tract infecon with CMV and TB.
Acknowledgments
Financial support for this study was provided by a grant from
the Golestan University of Medical Sciences, Gorgan, Iran with
a grant number IR.GOUMS.REC.1398.114. The authors wish to
thank the Laboratory Sciences Research Center and Department
of Microbiology of Golestan University of Medical Sciences,
the Ilamic Azad Universies of Tehran, Rasht, and Karaj, Liver
and Pancreatobiliary and Digesve Diseases Research Centers,
Sharia Hospital, Tehran University of Medical Sciences for their
spiritual supports.
Funding
A.M has received a grant (IR.GOUMS.REC.1398.114) from
Golestan University of Medical Sciences, Gorgan, Iran.
Conicts of Interest
No conicts of interest exist.
Figure 2 A schemac presentaon of GI tract infecon with CMV and
TB. Both may absorb from the upper GI tract and relocate
to a dierent part of the GI tract. However, it remains to
know whether or not they can exert from the colon.
Vol. 13 No. 7: 193
5
2022
© Under License of Creative Commons Attribution 3.0 License
Archives of Clinical Microbiology
1989-8436
References
1 Stein AC, Green N, Schwarzenberg SJ (2020) Gastrointesnal
Complicaons. 15: 321-34.
2 El-Zimaity H, Choi WT, Lauwers GY, Riddell R (2018) The dierenal
diagnosis of Helicobacter pylori negave gastris. Virchows Arch
473: 533-50.
3 Chouhan D, Devi TB, Chaopadhyay S, Dharmaseelan S, Devadas K,
et al. (2019) Mycobacterium abscessus infecon in the stomach of
paents with various gastric symptoms. PLoS Negl Trop Dis 13(11).
4 Chen D, Zhao R, Zhou W, Jiang Y, Zhang S, et al. (2020) Clinical
characteriscs of cytomegalovirus gastris: A retrospecve study
from a terary medical center. Medicine (Balmore) 99(5): 18927.
5 Lavery EA, Coyle WJ (2008) Herpes simplex virus and the alimentary
tract. Curr Gastroenterol Rep. 10(4): 417-23.
6 Clauditz TS, Wallace MB (2021) Lauwers GY Inammatory Disorders
of the Stomach. Gastrointest Pathol 73-98.
7 Schleiss MR (2019) Cytomegalovirus Matern Immun 11: 253-88.
8 Bernard S, Germi R, Lupo J, Laverrière MH, Masse V et al. (2015)
Symptomac cytomegalovirus gastrointesnal infecon with posive
quantave real-me PCR ndings in apparently immunocompetent
paents: A case series. Clin Microbiol Infect 21: 11-21.
9 Péter A, Telkes G, Varga M, Sárváry E, Kovalszky I, et al. (2004)
Endoscopic diagnosis of cytomegalovirus infecon of upper
gastrointesnal tract in solid organ transplant recipients: Hungarian
single-center experience. Clin Transplant 18(5): 580-4.
10 Boareo Teixeira Fernandes M, Nogueira Moisés Cardoso PA, Bassani
Altoé L, Almeida Rosa Da Silva G (2018) Gastrointesnal CMV Disease
and Tuberculosis in an AIDS Paent: Synergisc Interacon between
Opportunisc Coinfecons. Case Rep Med.
11 Marra CM (2018) other central nervous system infecons:
cytomegalovirus, Mycobacterium tuberculosis, and Treponema
pallidum. Handb Clin Neurol 152:151-66.
12 Cobelens F, Nagelkerke N, Fletcher H (2018) the convergent
epidemiology of tuberculosis and human cytomegalovirus infecon.
F1000Research 7.
13 Casllo G, Argyropoulos K, Moen FM, Bhakta D (2020) Gastrointesnal
Bleeding in a Paent With Gastric Lymphoma, Tuberculosis Enteris,
and Cytomegalovirus Enteris. ACG Case Reports J 7: 00317.
14 Mohebbi A, Mamizadeh Z, Bagheri H, Sharifnezhad F, Tabarraei A, et
al. (2020) Prevalent latent human cytomegalovirus genotype b2 in
biopsy samples of gastric cancer. Future Virol 15: 71-8.
15 Mirarab A, Mohebbi A, Moradi A, Javid N, Vakili MA, et al. (2017)
Frequent pUL27 Variaons in HIV-Infected Paents. Intervirology 59:
262-6.
16 Mirarab A, Mohebbi A, Javid N, Moradi A, Vakili MA, et al. (2017)
Human cytomegalovirus pUL97 drug-resistance mutaons in
congenitally neonates and HIV-infected, no-drug-treated paents.
Future Virol 12(1): 13-8.
17 Jang HJ, Kim AS, Hwang JB (2012) Cytomegalovirus-associated
esophageal ulcer in an immunocompetent infant: When should
ganciclovir is administered. Korean J Pediatr. Dec 15 55: 491-3.
18 Yi F, Zhao J, Luckheeram RV, Wang C, Huang S, et al. (2013) The
prevalence and risk factors of cytomegalovirus infecon in inammatory
bowel disease in Wuhan, Central China. Virol J 10(1): 43.
19 Li W, Fan H, Yiping L (2009) Postural Epigastric Pain as a Sign of
Cytomegalovirus Gastris in Renal Transplant Recipients: A Case-
Based Review. Transplant Proc 41: 3956-8.
Vol. 13 No. 7: 193
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Bleeding from the small bowel can be challenging to identify by endoscopic or radiographic evaluation. We present the case of a patient with incompletely treated latent tuberculosis and medical history of T-cell lymphoma who developed gastrointestinal bleeding because of concurrent Burkitt lymphoma, tuberculosis enteritis, and cytomegalovirus enteritis. The interplay of these 3 diagnoses is discussed.
Article
Full-text available
The AIDS pandemic has made diseases such as tuberculosis, CMV disease, and other opportunistic infections more prevalent; these diseases may even be found to be associated among themselves, and the natural history of each disease may present in an unusual manner. We report the case of a 41-year-old man with HIV (CD4 of 144 cells/dL) and HCV with hematochezia due to tuberculosis in the ileocecal valve and descending colon and CMV tissue invasive disease in the esophagus and descending colon. Coinfection among tuberculosis and cytomegalovirus in the gastrointestinal tract was described only once in a patient with a recent diagnosis of HIV that affected the distal ileum and ascending colon. We will discuss the peculiarities of the case and the behavior of the immune system in the face of simultaneous opportunistic infections. This is a challenging scenario that has scarce publications and is of great clinical importance.
Article
Full-text available
Although several factors are known to increase the risk of tuberculosis, the occurrence of tuberculosis disease in an infected individual is difficult to predict. We hypothesize that active human cytomegalovirus infection due to recent infection, reinfection or reactivation plays an epidemiologically relevant role in the aetiology of tuberculosis by precipitating the progression from latent tuberculosis infection to disease. The most compelling support for this hypothesis comes from the striking similarity in age-sex distribution between the two infections, important because the age-sex pattern of tuberculosis disease progression has not been convincingly explained. Cytomegalovirus infection and tuberculosis have other overlapping risk factors, including poor socio-economic status, sexual contact, whole blood transfusion and solid organ transplantation. Although each of these overlaps could be explained by shared underlying risk factors, none of the epidemiological observations refute the hypothesis. If this interaction would play an epidemiologically important role, important opportunities would arise for novel approaches to controlling tuberculosis.
Article
Full-text available
Background: The etiology of inflammatory bowel disease (IBD) is not clear and cytomegalovirus (CMV) infection is often associated with IBD patients. The etiologic link between IBD and CMV infection needs to be studied. The objective of the present study is to investigate the prevalence and risk factors of CMV in a cohort of IBD patients from Central China. Methods: Two hundred and twenty six IBD patients (189 ulcerative colitis (UC) and 37 patients with Crohn's disease (CD)), and 290 age and sex matched healthy controls were recruited. CMV DNA was detected by nested PCR, while serum anti-CMV IgG and anti-CMV IgM was determined by ELISAs. Colonoscopy/enteroscopy with biopsy of diseased tissues and subsequent H&E stain were then conducted in IBD patients with positive anti-CMV IgM. Finally, we analyzed the prevalence and clinical risk factors of CMV infection in IBD patients. Results: The prevalence of CMV DNA and anti-CMV IgG positive rate in IBD patients were 84.07% and 76.11%, respectively, higher than those in healthy controls (59.66% and 50.69%, respectively, P < 0.05), However, anti-CMV IgM positive rate was no different with healthy controls (1.77% vs 0.34%, P = 0.235). In univariate analysis of risk factors, the recent use of corticosteroid was associated with increase of CMV DNA and IgM positive rate in UC (P = 0.035 and P = 0.015, respectively), aminosalicylic acid drug therapy was correlated with positivity of CMV DNA and IgG in UC and CMV DNA in CD (P = 0.041, P < 0.001 and P = 0.014, respectively), the treatment of immunosuppresent was correlated with CMV IgM (P < 0.001). Furthermore, patients with severe UC were significantly associated with CMV DNA and IgM (P = 0.048 and P = 0.031, respectively). Malnutrition (albumin < 35 G/L) was also found to be related with CMV recent infection (P = 0.031). In multivariate analysis of risk factors in UC, pancolitis was significantly associated with CMV DNA positivity (P = 0.001). Severe UC and pancolitis seemed to be related with IgG positivity. For CD, there was just single factor associated with CMV positive in each group, multivariate analysis was unnecessary. Conclusions: CMV positive rate in IBD patients was significantly higher, than in healthy controls. The use of aminosalicylic acid, corticosteroid, immunosuppressants, pancolitis and severe IBD patients seemed to be more susceptible to CMV infection in univariate analysis of risk factors. However, no risk factor was found to be significantly correlated with CMV infection in multivariate analysis of risk factors.
Article
Full-text available
Cytomegalovirus (CMV)-associated esophageal ulcer is rare in immunocompetent infants. The presence of inclusion bodies and immunohistochemical staining for CMV in biopsy specimens obtained during esophagogastroduodenoscopy (EGD) indicate that such ulcers occur because of CMV infection. A 7-week-old female infant who experienced frequent vomiting and feeding intolerance was diagnosed with a massive CMV-associated ulcer in the distal esophagus. The ulcer improved after conservative treatment using proton-pump inhibitors; however, ganciclovir was not administered. In a follow-up EGD biopsy specimen, no CMV inclusion bodies were present, and immunohistochemical staining results for this virus were negative. The presence of CMV inclusion bodies indicates active viral replication. If persistent inclusion bodies or positive immunohistochemical staining for CMV is observed in follow-up biopsy specimens, ganciclovir may be used to treat CMV-associated esophageal ulcers.
Article
Aim: Genotyping and prevalence of human cytomegalovirus (HCMV) in gastrointestinal tract remains unclear. Objective: Characterization of HCMV and its viral load in samples of patients with gastric cancer (GC) in northeast Iran. Methods: A total of 21 biopsies were collected from patients with GC. HCMV was detected and genotyped using multiplex nested PCR. Quantitative real-time PCR has been used to determine the viral load. Staining was performed to detect viral inclusions. Results: 76.19% of the samples had HCMV genotypic b2 with viral load <0.1 IU/μl. 66.67% of patients were positive for H. pylori. Conclusion: Multiplex nested-PCR method can detect CMV populations with low viral loads in GC biopsies. For the first time, it was determined that the genotype b2 of HCMV is prevalent in the gastrointestinal tract.
Article
Objective: Drug-resistant isolates of human cytomegalovirus (HCMV) have led to the development of new anti-HCMV drugs. Maribavir (MBV) is a novel inhibitor of the HCMV viral kinase. Resistance to MBV is mapped to gene UL27, a viral nuclear protein. In this study, we investigated UL27 polymorphisms in MBV-naive HIV-positive and HCMV congenitally infected clinical samples. Methods: DNA was extracted from 20 CMV-positive HIV (9/20) and congenitally infected (11/20) patients and used for UL27 polymerase chain reaction amplification. Sanger sequencing and multiple sequence alignment of products was performed. Results: K90 was the most prevalent polymorphism in both HIV-positive and congenitally infected patients. Polymorphisms Q54, D123, and R107 (10%) were seen in more than one sample. There were significantly more polymorphisms in the HIV-positive samples (p = 0.038). Conclusion: HCMV pUL27 is highly variable in adult immunocompromised HIV-positive patients.
Article
Aim: Human cytomegalovirus (HCMV) treatment is hard to achieve because of viral protein target sequence variations. Objectives: We aimed to find HCMV pUL97 kinase variations in HIV- and congenitally infected patients. Methods: Twenty HCMV-positive DNA samples from nonganciclovir treated congenitally infected neonates and HIV positive patients were used for PCR restriction fragment length polymorphism. Variations were assessed computationally for pUL97 functionality. Results: P521L, D605E and N597Y substitutions were prevalent significantly in congenital infection. Furthermore, we found those mutations have neutral or low impact on pUL97 functionality. In addition, we found a new K599Q substitution in an HIV-infected individual. Conclusion: More prevalent substitutions related to low-grade ganciclovir resistance were found in congenitally infected neonates in comparison with HIV-infected patients.
Article
CMV gastrointestinal disease rarely occurs in immunocompetent patients and is mainly diagnosis based on histopathological findings. Real time PCR for CMV DNA quantification is considered as a useful diagnostic tool, but its place in the diagnostic strategy is not clearly defined. To describe the clinical and paraclinical features of apparently immunocompetent patients with CMV gastrointestinal disease diagnosed by quantitative PCR results. In this retrospective study conducted in a 1500-bed tertiary care center, we have reviewed the case records of apparently immunocompetent patients with positive finding of CMV DNA in gastrointestinal biopsies with compatible symptoms and endoscopic findings. A total of 13 patients were included between January 2007 and December 2010. The median age was 81 years and 54% of patients had underlying immune modulating conditions. Diarrhea, hematochezia and dysphagia were the main reported symptoms and ulcers were the main endoscopic findings. The mean value of CMV DNA load in gastrointestinal biopsies was 3845 copies/μg total DNA (range, 15-15500). The highest values were found in two patients who were diagnosed with adenocarcinoma in the following course of CMV infection. Clinical features were similar to previous series in which diagnosis was based on histopathological analysis. Elderly people are more commonly affected and a link with immune senescence is possible. Quantification of CMV DNA seems to be a useful tool for diagnosis when combined with clinical and endoscopic findings, but further studies are necessary to interpret quantitative values. Copyright © 2015. Published by Elsevier Ltd.
Article
Cytomegalovirus (CMV) is considered to be the major cause of upper gastrointestinal (GI) symptoms in organ transplant recipients. In the diagnosis of GI CMV infection the detection of the virus in the mucosa is essential. The aim of the study was to evaluate the significance of CMV, detected in biopsy specimens from stomach and duodenum of solid organ transplant recipients. Data of 227 elective upper endoscopies on symptomatic organ transplant recipients were evaluated for clinical symptoms, endoscopic changes and conventional histologic alterations of mucosal biopsy samples. Qualitative PCR was performed for detection of the presence of CMV-DNA in each biopsy materials. CMV-DNA was detected in biopsy samples of 91 patients (40.1%) while only in 20 cases (8.8%) the signs of CMV infections were found by conventional histology (p < 0.00001). No considerable differences could be observed in symptomatic, histologic alterations between CMV-PCR positive and negative groups. There were no endoscopic changes in 25.3% of CMV-PCR positive and 5.1% of negative patients. Qualitative PCR is an accurate method for the detection of CMV in the mucosa of the GI tract. Further investigations are needed for determination of the exact pathological role of detected CMV.